This intervention development and proof-of-concept study addresses the need for a developmentally tailored, flexible intervention that targets risk factors and features of children with SITBs. We will systematically and iteratively adapt and combine existing EBIs for children targeting emotion dysregulation and executive functioning for SITBs and evaluate feasibility and safety of SURE-Kids, as well as need for additional adaptation, in a Phase 0 trial with 18 children and caregiver(s).
The adapted intervention will be piloted in a single-arm trial with 18 children and families recruited through emergency department referrals at Children's Hospital Colorado, using suicide risk assessment and triage procedures already in place. Study team tracking and post-treatment interviews with clinicians, children, and families will identify additional, needed adaptations to the intervention. Feasibility of recruitment, retention, measurement, and intervention will be evaluated through study team-collected metrics, descriptive statistics, and mixed methods approaches. Safety will be evaluated through tracking and monitoring of adverse events, and indications of efficacy will be evaluated through exploration of changes in SITBs, symptoms, emotion dysregulation, and executive functioning.
18 Children: 1) between ages 7-12; 2) at least one caregiver/legal guardian consenting to participate in the study with the child as a dyad; 3) 1 or more episodes of active SI or NSSI, or a suicide attempt, within the last month.
Protocol Number: 24-1783
Principal Investigator